DYSF promotes monocyte activation in atherosclerotic cardiovascular disease as a DNA methylation-driven gene
Authors:
- 20 April 2022
- journal article
- research article
- Published by Elsevier in Translational Research
- Vol. 247, 19-38
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81871722, 82002235, 82072373)
- Wuhan University (ZNJC201932, ZNLH201907, znpy2019049, znpy2019054)
This publication has 44 references indexed in Scilit:
- RCircos: an R package for Circos 2D track plotsBMC Bioinformatics, 2013
- Dysferlin Regulates Cell Adhesion in Human MonocytesJournal of Biological Chemistry, 2013
- Two common mutations (p.Gln832X and c.663+1G>C) account for about a third of the DYSF mutations in Korean patients with dysferlinopathyNeuromuscular Disorders, 2012
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene ClustersOMICS: A Journal of Integrative Biology, 2012
- Muscle membrane repair and inflammatory attack in dysferlinopathySkeletal Muscle, 2011
- A New Role for the Muscle Repair Protein Dysferlin in Endothelial Cell Adhesion and AngiogenesisArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Emerging Role of IL-17 in AtherosclerosisJournal of Innate Immunity, 2010
- DNA methylation inhibits p53-mediated survivin repressionOncogene, 2009
- Hypermethylation of let-7a-3 in Epithelial Ovarian Cancer Is Associated with Low Insulin-like Growth Factor-II Expression and Favorable PrognosisCancer Research, 2007
- The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and strokeNature Genetics, 2004